← ALL EVENTS
HIGH CONFIDENCEBLIND SPOTFIRST OBSERVED 3 MONTHS AGO

Rep. Richard Dean Dr McCormick discloses trade(s) in ABT, ADI, BLK, CSCO, ICE

Richard Dean Dr McCormick (GA06) disclosed 15 transactions, traded Jun 12: 5 purchases and 10 sales.

TradedTickerCompanyActionAmountOwner
Jun 12ABTAbbott LaboratoriesBuy$1,001 - $15,000Self
Jun 12ABTAbbott LaboratoriesBuy$1,001 - $15,000Self
Jun 12ADIGrowth Partners Roth IRA Analog Devices, Inc.Sell (partial)$1,001 - $15,000Self
Jun 12ADIGrowth Partners Roth IRA Analog Devices, Inc.Sell (partial)$1,001 - $15,000Self
Jun 12BLKBlackRock, Inc.Sell (partial)$1,001 - $15,000Self
Jun 12CSCOCisco Systems, Inc.Sell (partial)$1,001 - $15,000Self
Jun 12CSCOCisco Systems, Inc.Sell (partial)$1,001 - $15,000Self
Jun 12ICEGrowth Partners Roth IRA Intercontinental Exchange Inc.Buy$1,001 - $15,000Self
Jun 12IMCBIshares Morningstar ETF Mid CapSell (partial)$1,001 - $15,000Self
Jun 12LHXETF L3Harris Technologies, Inc.Buy$1,001 - $15,000Self
Jun 12LHXL3Harris Technologies, Inc.Buy$1,001 - $15,000Self
Jun 12SPSMGrowth Partners Roth IRA State Street SPDR ETF Portfolio S&P 600 SmallSell (partial)$1,001 - $15,000Self
Jun 12UNHETF UnitedHealth Group IncorporatedSell (partial)$1,001 - $15,000Self
Jun 12UNHUnitedHealth Group IncorporatedSell (partial)$1,001 - $15,000Self
Jun 12MGKETF Vanguard Mega Cap Growth ETFSell (partial)$1,001 - $15,000Self

ORIGINAL FILING ↗ALL FILINGS BY RICHARD DEAN DR MCCORMICK →CONGRESS TRADES DASHBOARD →

Amounts are the ranges members report. Rows are read automatically from the filing; a trade split across a page break can be missed, so the original filing is the full record.

What This Means

A U.S. representative has filed financial disclosures covering equity transactions in five companies spanning healthcare, semiconductors, asset management, networking, and financial infrastructure. Congressional stock trading disclosures are public record and subject to the STOCK Act, which requires timely reporting. Such filings are tracked by markets observers and governance-focused investors monitoring potential conflicts of interest or information asymmetries among lawmakers.

Sources — 1 tier

Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.

How This Could Play Out — recorded when first flagged, not updated

Resolve

UNLIKELY

Enhanced transparency around congressional trading could reinforce confidence in market-level governance if disclosure rules are tightened or enforcement mechanisms are strengthened, though individual stock movements would depend on the underlying business fundamentals of the companies involved.

Left Unattended

LIKELY

The disclosure remains a routine filing with no material market consequence, as these transactions fall within standard portfolio rebalancing ranges and the companies involved are large-cap holdings common across diversified institutional and retail portfolios.

Escalate

POSSIBLE

If the timing or pattern of these trades triggers scrutiny for potential insider trading or conflicts of interest—particularly if correlated with subsequent legislative action affecting these sectors—it could fuel renewed calls for stricter congressional trading restrictions and create reputational pressure on the representative and broader sentiment around legislative integrity.

SPONSORED

Confidence History

  • HIGH CONFIDENCESep 30, 2026 at 6:03 AM

    Legally mandated financial disclosure filing -- primary source, not a report about the event